FEDERAL · 35 U.S.C. · Chapter 32
Conduct of post-grant review
35 U.S.C. § 326
Title35 — Patents
Chapter32 — POST-GRANT REVIEW
This text of 35 U.S.C. § 326 (Conduct of post-grant review) is published on Counsel Stack Legal Research, covering United States primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.
Bluebook
35 U.S.C. § 326.
Text
(a)Regulations.—The Director shall prescribe regulations—
(1)providing that the file of any proceeding under this chapter shall be made available to the public, except that any petition or document filed with the intent that it be sealed shall, if accompanied by a motion to seal, be treated as sealed pending the outcome of the ruling on the motion;
(2)setting forth the standards for the showing of sufficient grounds to institute a review under subsections (a) and (b) of section 324;
(3)establishing procedures for the submission of supplemental information after the petition is filed;
(4)establishing and governing a post-grant review under this chapter and the relationship of such review to other proceedings under this title;
(5)setting forth standards and procedures for discovery of
Free access — add to your briefcase to read the full text and ask questions with AI
Related
Virtualagility Inc. v. salesforce.com, Inc.
759 F.3d 1307 (Federal Circuit, 2014)
Versata Development Group, Inc. v. SAP America, Inc.
793 F.3d 1306 (Federal Circuit, 2015)
Aqua Products, Inc. v. Matal
872 F.3d 1290 (Federal Circuit, 2017)
Sightsound Technologies, LLC v. Apple Inc.
809 F.3d 1307 (Federal Circuit, 2015)
Return Mail, Inc. v. United States Postal Service
868 F.3d 1350 (Federal Circuit, 2017)
Intellectual Ventures II LLC v. Jpmorgan Chase & Co.
781 F.3d 1372 (Federal Circuit, 2015)
Versata Software, Inc. v. Callidus Software, Inc.
41 F. Supp. 3d 414 (D. Delaware, 2014)
Medytox, Inc. v. Galderma S.A.
(Federal Circuit, 2023)
Genentech, Inc. v. Eli Lilly and Company
(S.D. California, 2021)
DynaEnergetics Europe GmbH v. Nexus Perforating LLC
(S.D. Texas, 2021)
L'Oreal USA, Inc. v. Olaplex, Inc.
(Federal Circuit, 2021)
Purdue Pharma L.P. v. Collegium Pharmaceutical, Inc.
86 F.4th 1338 (Federal Circuit, 2023)
Simpson Strong-Tie Company Inc. v. Columbia Insurance Company
(Federal Circuit, 2025)
OANDA CORPORATION v. GAIN CAPITAL HOLDINGS, INC.
(D. New Jersey, 2021)
Source Credit
History
(Added Pub. L. 112–29, §6(d), Sept. 16, 2011, 125 Stat. 308.)
Editorial Notes
Statutory Notes and Related Subsidiaries
Effective Date
Section effective upon the expiration of the 1-year period beginning Sept. 16, 2011, and applicable only to patents described in section 3(n)(1) of Pub. L. 112–29 (35 U.S.C. 100 note), with certain exceptions and limitations, see section 6(f)(2), (3) of Pub. L. 112–29, set out as a note under section 321 of this title.
Effective Date
Section effective upon the expiration of the 1-year period beginning Sept. 16, 2011, and applicable only to patents described in section 3(n)(1) of Pub. L. 112–29 (35 U.S.C. 100 note), with certain exceptions and limitations, see section 6(f)(2), (3) of Pub. L. 112–29, set out as a note under section 321 of this title.
Cite This Page — Counsel Stack
Bluebook (online)
35 U.S.C. § 326, Counsel Stack Legal Research, https://law.counselstack.com/usc/35/326.